Found: 68
Select item for more details and to access through your institution.
The impact of left anterior descending coronary artery length on survival following myocardial infarction: To the apex and beyond.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
High-risk coronary anatomy versus high-risk physiology as outcome predictors in acute coronary syndromes.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Remote ischemic preconditioning in elective percutaneous coronary intervention does not protect myocardium nor mobilize endothelial progenitor cells.
- Published in:
- Catheterization & Cardiovascular Interventions, 2013, v. 81, n. 6, p. 937, doi. 10.1002/ccd.24930
- By:
- Publication type:
- Article
Zotarolimus-eluting stents among patients with renal impairment undergoing percutaneous coronary intervention.
- Published in:
- Catheterization & Cardiovascular Interventions, 2012, v. 80, n. 6, p. 893, doi. 10.1002/ccd.24686
- By:
- Publication type:
- Article
2012 American college of cardiology foundation/society for cardiovascular angiography and interventions expert consensus document on cardiac catheterization laboratory standards update: American college of cardiology foundation task force on expert consensus documents society of thoracic surgeons society for vascular medicine
- Published in:
- Catheterization & Cardiovascular Interventions, 2012, v. 80, n. 3, p. E37, doi. 10.1002/ccd.24466
- By:
- Publication type:
- Article
Early and late outcome associated with bleeding events in the setting of dual antiplatelet therapy following stent placement.
- Published in:
- Catheterization & Cardiovascular Interventions, 2012, v. 80, n. 3, p. 406, doi. 10.1002/ccd.24566
- By:
- Publication type:
- Article
Contemporary occurrence of stent thrombosis in clinical practice: Better never than late.
- Published in:
- Catheterization & Cardiovascular Interventions, 2012, v. 79, n. 4, p. 557, doi. 10.1002/ccd.24343
- By:
- Publication type:
- Article
Creating biodegradable-polymer drug-eluting stents: Shortening the duration of polymer and dual antiplatelet therapy while lengthening the follow-up.
- Published in:
- Catheterization & Cardiovascular Interventions, 2012, v. 79, n. 2, p. 217, doi. 10.1002/ccd.24294
- By:
- Publication type:
- Article
A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: The tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial
- Published in:
- Catheterization & Cardiovascular Interventions, 2011, v. 77, n. 7, p. 1001, doi. 10.1002/ccd.22876
- By:
- Publication type:
- Article
unfractionated versus low-molecular-weight heparin for primary angioplasty-More data suggesting to go low.
- Published in:
- Catheterization & Cardiovascular Interventions, 2011, v. 77, n. 2, p. 191, doi. 10.1002/ccd.22953
- By:
- Publication type:
- Article
Randomized trial versus registry data—comparing apples and ORCHIDs.
- Published in:
- Catheterization & Cardiovascular Interventions, 2006, v. 68, n. 5, p. 669, doi. 10.1002/ccd.20804
- By:
- Publication type:
- Article
Imminent extinction of brachy(saurus)therapy for the treatment of in‐stent restenosis.
- Published in:
- Catheterization & Cardiovascular Interventions, 2006, v. 68, n. 3, p. 349, doi. 10.1002/ccd.20867
- By:
- Publication type:
- Article
The relationship of obesity to ischemic outcomes following coronary stent placement in contemporary practice.
- Published in:
- Catheterization & Cardiovascular Interventions, 2006, v. 67, n. 4, p. 563, doi. 10.1002/ccd.20622
- By:
- Publication type:
- Article
Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel.
- Published in:
- Catheterization & Cardiovascular Interventions, 2005, v. 64, n. 3, p. 369
- By:
- Publication type:
- Article
Real‐world bare metal stenting: Identification of patients at low or very low risk of 9‐month coronary revascularization.
- Published in:
- Catheterization & Cardiovascular Interventions, 2004, v. 63, n. 2, p. 135, doi. 10.1002/ccd.20132
- By:
- Publication type:
- Article
The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable.
- Published in:
- Catheterization & Cardiovascular Interventions, 2001, v. 54, n. 4, p. 497, doi. 10.1002/ccd.1320
- By:
- Publication type:
- Article
Thrombolytic therapy for acute myocardial infarction.
- Published in:
- Catheterization & Cardiovascular Interventions, 2001, v. 53, n. 4, p. 489, doi. 10.1002/ccd.1208
- By:
- Publication type:
- Article
QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study.
- Published in:
- EP: Europace, 2014, v. 16, n. 6, p. 803
- By:
- Publication type:
- Article
Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Prognostic Importance of Physical Examination for Heart Failure in Non–ST-Elevation Acute Coronary Syndromes: The Enduring Value of Killip Classification.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 290, n. 16, p. 2174, doi. 10.1001/jama.290.16.2174
- By:
- Publication type:
- Article
Early Statin Initiation and Outcomes in Patients With Acute Coronary Syndromes.
- Published in:
- JAMA: Journal of the American Medical Association, 2002, v. 287, n. 23, p. 3087, doi. 10.1001/jama.287.23.3087
- By:
- Publication type:
- Article
Troponins in Acute Coronary Syndromes.
- Published in:
- 2001
- By:
- Publication type:
- Editorial
The Timely Coupling of Mechanical Revascularization following Thrombolysis for Myocardial Infarction.
- Published in:
- Cardiology, 2007, v. 107, n. 4, p. 337, doi. 10.1159/000099047
- By:
- Publication type:
- Article
Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients.
- Published in:
- Human Genetics, 2003, v. 114, n. 1, p. 87, doi. 10.1007/s00439-003-1026-1
- By:
- Publication type:
- Article
Drug-Coated Balloons for In-Stent Restenosis—Finally Leaving Nothing Behind for US Patients.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 12, p. 1011, doi. 10.1001/jama.2024.0813
- By:
- Publication type:
- Article
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials.
- Published in:
- European Heart Journal, 2010, v. 31, n. 1, p. 35, doi. 10.1093/eurheartj/ehp376
- By:
- Publication type:
- Article
Options and outcomes with different antiplatelet strategies during primary percutaneous coronary intervention.
- Published in:
- European Heart Journal, 2009, v. 30, n. 14, p. 1687, doi. 10.1093/eurheartj/ehp191
- By:
- Publication type:
- Article
Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes.
- Published in:
- European Heart Journal, 2006, v. 27, n. 24, p. 2956, doi. 10.1093/eurheartj/ehl356
- By:
- Publication type:
- Article
International variation in invasive care of the elderly with acute coronary syndromes.
- Published in:
- European Heart Journal, 2006, v. 27, n. 13, p. 1558, doi. 10.1093/eurheartj/ehl067
- By:
- Publication type:
- Article
Are tirofiban and abciximab identical in efficacy?: reply.
- Published in:
- European Heart Journal, 2006, v. 27, n. 1, p. 120
- By:
- Publication type:
- Article
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up.
- Published in:
- European Heart Journal, 2005, v. 26, n. 23, p. 2524, doi. 10.1093/eurheartj/ehi459
- By:
- Publication type:
- Article
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.
- Published in:
- European Heart Journal, 2005, v. 26, n. 2, p. 128, doi. 10.1093/eurheartj/ehi061
- By:
- Publication type:
- Article
Effectiveness of Drug-Eluting Stents in Real-World Patients.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Brachytherapy for In-Stent Restenosis.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Clopidogrel for Percutaneous Coronary Revascularization: Time for More Pretreatment, Retreatment, or Both?
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Relationship of Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary Syndromes.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 292, n. 13, p. 1555, doi. 10.1001/jama.292.13.1555
- By:
- Publication type:
- Article
Fractionating Heparin—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 292, n. 12, p. 1427, doi. 10.1001/jama.292.12.1427-c
- By:
- Publication type:
- Article
Fractionating Heparins and Their Clinical Trial Data--Something for Everyone.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 292, n. 1, p. 101, doi. 10.1001/jama.292.1.101
- By:
- Publication type:
- Article
Acute Coronary Syndromes Among Patients with Prior Coronary Artery Bypass Surgery.
- Published in:
- Current Cardiology Reports, 2022, v. 24, n. 11, p. 1755, doi. 10.1007/s11886-022-01784-4
- By:
- Publication type:
- Article
Editorial: Protein C and S Deficiency as a Risk Factor for Stent Thrombosis-When a Rare Disorder Can Predispose to Rare Events.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Advances in Antiplatelet Therapy for ACS and PCI.
- Published in:
- Journal of Interventional Cardiology, 2008, v. 21, p. S18, doi. 10.1111/j.1540-8183.2008.00409.x
- By:
- Publication type:
- Article
Increased doses of clopidogrel or aspirin did not prevent cardiovascular events.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
2010 - Increased doses of clopidogrel or aspirin did not prevent cardiovascular events.
- Published in:
- ACP Journal Club, 2011, v. 154, n. 1, p. 6
- By:
- Publication type:
- Article
The Role of the Platelet in the Pathogenesis of Atherothrombosis.
- Published in:
- American Journal of Cardiovascular Drugs, 2005, v. 5, n. 6, p. 399, doi. 10.2165/00129784-200505060-00007
- By:
- Publication type:
- Article
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Monitoring Antiplatelet Therapy.
- Published in:
- Clinical Pharmacokinetics, 2000, v. 39, n. 6, p. 445, doi. 10.2165/00003088-200039060-00005
- By:
- Publication type:
- Article
CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions: One Size Rarely Fits All.
- Published in:
- 2020
- By:
- Publication type:
- Editorial